Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HEXCEL CORP /DE/HXL · Entity 3705 | Director | October 02, 2026 | October 05, 2026 |
| Ingevity CorpNGVT · Entity 4401 | Director · President & CEO | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HEXCEL CORP /DE/
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,952 |
Reported balance
After 2026-10-03 transaction · row 1
1 source rowRow 1 · 2026-10-03 · Exercise / conversion · Acquired 340 · Balance 4,952 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 287 |
Reported balance
After 2026-10-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-02 · Grant · Acquired 287 · Balance 287 F1: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-10-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-03 · Exercise / conversion · Disposed 340 · Balance 0 F1: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer.
F2: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant.
Ingevity Corp
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 120,544 |
Ending reported balance
After 2026-08-18 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-08-14 · Sale · Disposed 5,000 · Balance 125,636 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.82 to $76.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 5,000 · Balance 120,636 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $76.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-18 · Sale · Disposed 92 · Balance 120,544 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.39 to $74.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.82 to $76.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $76.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.39 to $74.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CMC Materials, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-07-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-07-06 · Disposition to issuer · Disposed 73,743.1139 · Balance 0 F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock. Row 2 · 2022-07-06 · Grant · Acquired 74,535 · Balance 74,535 F2: Reflects the conversion of performance share units with respect to Issuer common stock ("PSUs") into time-based restricted stock units with respect to Entegris common stock ("RSUs") in accordance with the Merger Agreement. Transaction represents the satisfaction of all performance vesting conditions at the target level of performance in connection with the Merger pursuant to the terms of the Merger Agreement. The RSUs remain subject to time-based vesting requirements and are convertible into shares of Entegris common stock on a one-for-one basis on the applicable vesting dates. Row 3 · 2022-07-06 · Disposition to issuer · Disposed 74,535 · Balance 0 F2: Reflects the conversion of performance share units with respect to Issuer common stock ("PSUs") into time-based restricted stock units with respect to Entegris common stock ("RSUs") in accordance with the Merger Agreement. Transaction represents the satisfaction of all performance vesting conditions at the target level of performance in connection with the Merger pursuant to the terms of the Merger Agreement. The RSUs remain subject to time-based vesting requirements and are convertible into shares of Entegris common stock on a one-for-one basis on the applicable vesting dates. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.27 · Expires 2026-12-05 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-07-06 · Disposition to issuer · Disposed 10,950 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F4: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2017, vested in full and was assumed and converted into an Entegris Option to purchase 19,935 shares of Entegris common stock an exercise price of $33.11 per share. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $92.57 · Expires 2027-12-05 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-07-06 · Disposition to issuer · Disposed 22,054 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F5: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2018, vested in full and was assumed and converted into an Entegris Option to purchase 40,151 shares of Entegris common stock an exercise price of $50.85 per share. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $101.73 · Expires 2028-12-06 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-07-06 · Disposition to issuer · Disposed 25,424 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F6: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2019, vested in full and was assumed and converted into an Entegris Option to purchase 46,286 shares of Entegris common stock an exercise price of $55.88 per share. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $127.48 · Expires 2029-12-05 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-07-06 · Disposition to issuer · Disposed 23,612 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F7: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2020, vested in full and was assumed and converted into an Entegris Option to purchase 42,988 shares of Entegris common stock an exercise price of $70.03 per share. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $145.58 · Expires 2030-12-03 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-07-06 · Disposition to issuer · Disposed 23,196 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F8: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/3/2021, vested in full and was assumed and converted into an Entegris Option to purchase 42,230 shares of Entegris common stock an exercise price of $79.97 per share. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $141.18 · Expires 2031-12-06 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-07-06 · Disposition to issuer · Disposed 21,105 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F9: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2022, vested in full and was assumed and converted into an Entegris Option to purchase 38,423 shares of Entegris common stock an exercise price of $77.55 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock.
F2: Reflects the conversion of performance share units with respect to Issuer common stock ("PSUs") into time-based restricted stock units with respect to Entegris common stock ("RSUs") in accordance with the Merger Agreement. Transaction represents the satisfaction of all performance vesting conditions at the target level of performance in connection with the Merger pursuant to the terms of the Merger Agreement. The RSUs remain subject to time-based vesting requirements and are convertible into shares of Entegris common stock on a one-for-one basis on the applicable vesting dates.
F3: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement).
F4: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2017, vested in full and was assumed and converted into an Entegris Option to purchase 19,935 shares of Entegris common stock an exercise price of $33.11 per share.
F5: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2018, vested in full and was assumed and converted into an Entegris Option to purchase 40,151 shares of Entegris common stock an exercise price of $50.85 per share.
F6: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2019, vested in full and was assumed and converted into an Entegris Option to purchase 46,286 shares of Entegris common stock an exercise price of $55.88 per share.
F7: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2020, vested in full and was assumed and converted into an Entegris Option to purchase 42,988 shares of Entegris common stock an exercise price of $70.03 per share.
F8: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/3/2021, vested in full and was assumed and converted into an Entegris Option to purchase 42,230 shares of Entegris common stock an exercise price of $79.97 per share.
F9: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2022, vested in full and was assumed and converted into an Entegris Option to purchase 38,423 shares of Entegris common stock an exercise price of $77.55 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2026 Filed Oct 5, 2026 22:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-414511 · ownership.xml · derivative · entry 3 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| October 03, 2026 Filed Oct 5, 2026 22:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-414511 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2026 Filed Oct 5, 2026 22:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 287 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-414511 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287 Underlying: Common Stock · 287 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| August 18, 2026 Filed Aug 18, 2026 21:14 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 92 | $74.71 | $6,873.32 |
DisclosureSEC source: 0001436880-26-000008 · wk-form4_1787087642.xml · nonDerivative · entry 3 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,544 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.39 to $74.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:14 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 5,000 | $75.83 | $379,150.00 |
DisclosureSEC source: 0001436880-26-000008 · wk-form4_1787087642.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,636 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $76.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:14 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 5,000 | $75.73 | $378,650.00 |
DisclosureSEC source: 0001436880-26-000008 · wk-form4_1787087642.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,636 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.82 to $76.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 21:06 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 5,000 | $75.73 | $378,650.00 |
DisclosureSEC source: 0001436880-26-000006 · wk-form4_1786741576.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,636 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.18 to $76.26, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 21:06 UTC | Ingevity Corp NGVT · Entity 4401 | SaleCommon Stock | 5,000 | $76.62 | $383,100.00 |
DisclosureSEC source: 0001436880-26-000006 · wk-form4_1786741576.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,636 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.14 to $78.22, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 22:49 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 239 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-302234 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239 Underlying: Common Stock · 239 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 22:49 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-302234 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2026 Filed May 19, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 1,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-231158 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,792 Underlying: Common Stock · 1,792 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. F2 · derivative.expiration_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. Read SEC document |
| May 08, 2026 Filed May 8, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 2,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-215091 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. F2 · derivative.expiration_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. Read SEC document |
| May 08, 2026 Filed May 8, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 2,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-215091 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:30 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 3,574 | $70.57 | $252,217.18 |
DisclosureSEC source: 0001436880-26-000004 · wk-form4_1775770211.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,636 Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:30 UTC | Ingevity Corp NGVT · Entity 4401 | Tax withholdingCommon Stock | 13,102 | $70.57 | $924,608.14 |
DisclosureSEC source: 0001436880-26-000004 · wk-form4_1775770211.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,210 F1 · balance_after: Includes 422 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP"), for the purchase period of January 1, 2026 to March 31, 2026. In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025. Read SEC document |
| April 04, 2026 Filed Apr 6, 2026 21:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-143956 · ownership.xml · derivative · entry 3 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| April 04, 2026 Filed Apr 6, 2026 21:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-143956 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2026 Filed Apr 6, 2026 21:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-143956 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277 Underlying: Common Stock · 277 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:30 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 38,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001436880-26-000002 · wk-form4_1772587808.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,890 F1 · shares: Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on February 27, 2027, 2028, and 2029. F2 · balance_after: Includes (i) 364 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP") for the purchase period of July 1, 2025 to September 30, 2025 (the "September ESPP Shares"), and (ii) 162 shares of Common Stock purchased pursuant to the ESPP for the purchase period of October 1, 2025 to December 31, 2025 (the "December ESPP Shares"). In accordance with the terms of the ESPP, the September ESPP Shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on July 1, 2025 and the December ESPP Shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on October 1, 2025. Read SEC document |
| January 10, 2026 Filed Jan 13, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-011794 · ownership.xml · derivative · entry 3 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| January 10, 2026 Filed Jan 13, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-011794 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:30 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 272 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-011794 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272 Underlying: Common Stock · 272 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 13:37 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-232790 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340 Underlying: Common Stock · 340 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 22:06 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095975 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373 Underlying: Common Stock · 373 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| July 10, 2025 Filed Jul 13, 2026 22:49 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-302234 · ownership.xml · derivative · entry 3 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:12 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 2,697 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-069216 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,697 Underlying: Common Stock · 2,697 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. F2 · derivative.expiration_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. Read SEC document |
| May 07, 2025 Filed May 8, 2025 20:37 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionRestricted Stock Units · Derivative | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-067101 · ownership.xml · derivative · entry 2 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 744 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. F2 · derivative.expiration_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. Read SEC document |
| May 07, 2025 Filed May 8, 2025 20:37 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | Exercise / conversionCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-067101 · ownership.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 21:28 UTC | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 177,305 | $0.00 Strike: $31.73 | $0.00 |
DisclosureSEC source: 0001653477-25-000053 · wk-form4_1744234083.xml · derivative · entry 3 Li David H · CIK 0001436880 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,305 Underlying: Common Stock · 177,305 shares Expires 2035-04-07 F3 · shares: These options are granted pursuant to the 2016 OIP. Such options will vest ratably in four installments on April 7, 2026, 2027, 2028 and 2029. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 21:28 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 31,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-25-000053 · wk-form4_1744234083.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,185 F2 · shares: Grant of RSUs pursuant to the 2016 OIP, which will vest ratably in four installments on April 7, 2026, 2027, 2028, and 2029. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 21:28 UTC | Ingevity Corp NGVT · Entity 4401 | GrantCommon Stock | 86,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001653477-25-000053 · wk-form4_1744234083.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,669 F1 · shares: Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan ("2016 OIP"), which will vest ratably in three installments on April 7, 2026, 2027, and 2028. Read SEC document |
| April 07, 2025 Filed Apr 17, 2025 20:38 UTC Amendment | Ingevity Corp NGVT · Entity 4401 | GrantEmployee Stock Option (right-to-buy) · Derivative | 123,229 | $0.00 Strike: $31.73 | $0.00 |
DisclosureSEC source: 0001653477-25-000055 · wk-form4a_1744922273.xml · derivative · entry 1 Li David H · CIK 0001436880 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,229 Underlying: Common Stock · 123,229 shares Expires 2035-04-07 F1 · shares: The original Form 4 filed on April 9, 2025 inadvertently reported an incorrect number of Employee Stock Options (right to buy) ("Options") granted to the reporting person due to a clerical error. This amendment reports the correct number of Options granted to the reporting person in the reported transaction. F2 · derivative.exercise_date: These Options will vest ratably in four installments on April 7, 2026, 2027, 2028 and 2029. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 13:28 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-051814 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457 Underlying: Common Stock · 457 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-004812 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341 Underlying: Common Stock · 341 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. F2 · derivative.expiration_date: The shares of common stock underlying the RSUs will be converted into an equivalent number of shares of common stock of the issuer on the first anniversary of the date of grant. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:00 UTC | HEXCEL CORP /DE/ HXL · Entity 3705 | GrantRestricted Stock Units · Derivative | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-001108 · ownership.xml · derivative · entry 1 Li David H · CIK 0001436880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744 Underlying: Common Stock · 744 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. F2 · derivative.expiration_date: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 21,105 | $0.00 Strike: $141.18 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 9 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,105 shares Expires 2031-12-06 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F9 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2022, vested in full and was assumed and converted into an Entegris Option to purchase 38,423 shares of Entegris common stock an exercise price of $77.55 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 23,196 | $0.00 Strike: $145.58 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 8 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,196 shares Expires 2030-12-03 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F8 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/3/2021, vested in full and was assumed and converted into an Entegris Option to purchase 42,230 shares of Entegris common stock an exercise price of $79.97 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 23,612 | $0.00 Strike: $127.48 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 7 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,612 shares Expires 2029-12-05 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F7 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2020, vested in full and was assumed and converted into an Entegris Option to purchase 42,988 shares of Entegris common stock an exercise price of $70.03 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 25,424 | $0.00 Strike: $101.73 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 6 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,424 shares Expires 2028-12-06 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F6 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/6/2019, vested in full and was assumed and converted into an Entegris Option to purchase 46,286 shares of Entegris common stock an exercise price of $55.88 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 22,054 | $0.00 Strike: $92.57 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 5 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,054 shares Expires 2027-12-05 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F5 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2018, vested in full and was assumed and converted into an Entegris Option to purchase 40,151 shares of Entegris common stock an exercise price of $50.85 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerStock Options (Right to Buy) · Derivative | 10,950 | $0.00 Strike: $60.27 | $0.00 |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · derivative · entry 4 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,950 shares Expires 2026-12-05 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding option to purchase shares of Issuer common stock (an "Issuer Option") vested in full and was assumed and converted into an option to purchase shares of Entegris common stock (an "Entegris Option"), as adjusted based on the Equity Award Exchange Ratio (as defined in the Merger Agreement). F4 · derivative.exercise_date: This Issuer Option, which originally provided for vesting in four equal annual installments beginning on 12/5/2017, vested in full and was assumed and converted into an Entegris Option to purchase 19,935 shares of Entegris common stock an exercise price of $33.11 per share. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerCommon Stock | 74,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · nonDerivative · entry 3 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Reflects the conversion of performance share units with respect to Issuer common stock ("PSUs") into time-based restricted stock units with respect to Entegris common stock ("RSUs") in accordance with the Merger Agreement. Transaction represents the satisfaction of all performance vesting conditions at the target level of performance in connection with the Merger pursuant to the terms of the Merger Agreement. The RSUs remain subject to time-based vesting requirements and are convertible into shares of Entegris common stock on a one-for-one basis on the applicable vesting dates. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | GrantCommon Stock | 74,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,535 F2 · price: Reflects the conversion of performance share units with respect to Issuer common stock ("PSUs") into time-based restricted stock units with respect to Entegris common stock ("RSUs") in accordance with the Merger Agreement. Transaction represents the satisfaction of all performance vesting conditions at the target level of performance in connection with the Merger pursuant to the terms of the Merger Agreement. The RSUs remain subject to time-based vesting requirements and are convertible into shares of Entegris common stock on a one-for-one basis on the applicable vesting dates. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 15:37 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Disposition to issuerCommon Stock | 73,743.1139 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-018915 · form4.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), by and among the Issuer, Entegris, Inc. ("Entegris") and Yosemite Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of Entegris, pursuant to which the Issuer was merged with and into Merger Sub, with the Issuer surviving as a wholly owned subsidiary of Entegris (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Issuer common stock was cancelled and converted into (i) $133.00 in cash and (ii) 0.4506 of a share of Entegris common stock, with cash in lieu of any fractional shares of Entegris common stock (together, the "Merger Consideration"). The Merger closed on July 6, 2022. On July 5, 2022, the closing price of the Issuer was $173.69, and the closing price of Entegris was $90.75. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Issuer common stock. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 12:09 UTC | CMC Materials, Inc. CCMP · Entity 125533 | GrantCommon Stock | 65.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018152 · form4.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,743.1139 Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 17:42 UTC | CMC Materials, Inc. CCMP · Entity 125533 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016226 · form4.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,677.8399 F1 · kind: This transaction reported involved a gift by the reporting person of 20,000 shares of common stock to a family charitable trust. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 08:13 UTC | CMC Materials, Inc. CCMP · Entity 125533 | GrantCommon Stock | 84.045 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000196 · form4.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,677.8399 Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 17:43 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Exercise / conversionStock Options (Right to Buy) · Derivative | 20,150 | $0.00 Strike: $60.27 | $0.00 |
DisclosureSEC source: 0001127602-21-031615 · form4.xml · derivative · entry 3 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,950 Underlying: Common Stock · 20,150 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 2016 (FY17) Non-Qualified Stock Option Grant Vesting Schedule: 25% 12/05/2017, 25% 12/05/2018, 25% 12/05/2019, 25% 12/05/2020. Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 17:43 UTC | CMC Materials, Inc. CCMP · Entity 125533 | SaleCommon Stock | 20,150 | $184.40 | $3,715,696.27 |
DisclosureSEC source: 0001127602-21-031615 · form4.xml · nonDerivative · entry 2 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,593.7949 F1 · kind: Sale to cover exercise price of, and taxes related to, cashless exercise of stock options. Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 17:43 UTC | CMC Materials, Inc. CCMP · Entity 125533 | Exercise / conversionCommon Stock | 20,150 | $60.27 | $1,214,440.50 |
DisclosureSEC source: 0001127602-21-031615 · form4.xml · nonDerivative · entry 1 Li David H · CIK 0001436880 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,743.7949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.